U.S. Markets close in 1 hr 34 mins

A Financial Overview of Veracyte for November

Daniel Collins
A Financial Overview of Veracyte for November

Veracyte (VCYT) generated revenue of $23.5 million in the third quarter compared to $17.5 million in the same period of the previous year, reflecting a ~34% YoY (year-over-year) rise. Veracyte generated net revenue of $66.3 million in the first nine months of the year compared to $52.4 million in the same period of the previous year, reflecting a rise of ~27% YoY. Veracyte’s revenue growth could boost the share price of the Invesco Russell 2000 Pure Growth ETF (PXSG).